• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Express Is Trading Higher By Over 21%, Here Are 54 Stocks Moving In Wednesday's Mid-Day Session

    8/31/22 12:47:22 PM ET
    $ALLK
    $AMBA
    $AMRK
    $APGN
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Semiconductors
    Technology
    Get the next $ALLK alert in real time by email

    Gainers

    • Nuwellis, Inc. (NASDAQ:NUWE) shares jumped 140% to $1.5894 after the company announced new clinical data demonstrating 100% survival at 30 days following the use of ultrafiltration in high-risk postoperative coronary artery bypass grafting patients.
    • Allakos Inc. (NASDAQ:ALLK) gained 47% to $5.94. Allakos recently posted a Q2 loss of $0.90 per share.
    • Yiren Digital Ltd. (NYSE:YRD) rose 39% to $0.98 after reporting unaudited financial results for the fourth quarter and the fiscal year ended December 31, 2021.
    • Mobilicom Limited (NASDAQ:MOB) shares climbed 31.5% to $3.2099. Mobilicom recently reported closing of initial public offering.
    • ZeroFox Holdings, Inc. (NASDAQ:ZFOX) shares gained 28.6% to $6.98.
    • Burning Rock Biotech Limited (NASDAQ:BNR) gained 19.7% to $3.89 following Q2 results.
    • Hour Loop, Inc. (NASDAQ:HOUR) rose 19.4% to $4.5150 after jumping 15% on Tuesday. Hour Loop recently posted a Q2 loss of $0.01 per share.
    • Meihua International Medical Technologies Co., Ltd. (NASDAQ:MHUA) gained 17.2% to $3.88.
    • Barnes & Noble Education, Inc. (NYSE:BNED) gained 16.8% to $2.64 after reporting upbeat quarterly sales.
    • Bausch Health Companies Inc. (NYSE:BHC) gained 15.5% to $5.91.
    • SuperCom Ltd. (NASDAQ:SPCB) climbed 13.7% to $0.3785. The company was recently announced it was awarded a $33 million national electronic monitoring contract with a EU member country.
    • ChargePoint Holdings, Inc. (NYSE:CHPT) climbed 12.9% to $16.36 after the company reported better-than-expected Q2 sales results.
    • Apexigen, Inc. (NASDAQ:APGN) gained 11.9% to $4.89.
    • Lottery.com Inc. (NASDAQ:LTRY) rose 11.7% to $0.3910 after dropping over 7% on Tuesday.
    • Mega Matrix Corp. (NYSE:MTMT) jumped 11.4% to $1.6927.
    • Snap Inc. (NYSE:SNAP) gained 11.1% to $11.12 after the company announced restructuring plans to increase focus on community growth, revenue growth and augmented reality. The company said it will reduce the size of its team by roughly 20%.
    • Cazoo Group Ltd (NYSE:CZOO) jumped 11.1% to $0.6810.
    • Lottery.com Inc. (NASDAQ:LTRY) gained 10.6% to $0.3871.
    • Molecular Data Inc. (NASDAQ:MKD) rose 9.7% to $0.4590 after declining around 12% on Tuesday.
    • Software Acquisition Group Inc. III (NASDAQ:NOGN) shares rose 9.6% to $3.67 after dropping over 65% on Tuesday.
    • Rocket Lab USA, Inc. (NASDAQ:RKLB) gained 9.6% to $5.63 after Cowen & Co. upgraded the stock from Market Perform to Outperform and raised its price target from $6.50 to $8.
    • Kala Pharmaceuticals, Inc. (NASDAQ:KALA) shares rose 9.2% to $0.3080. Kala Pharmaceuticals recently said it would focus its efforts on KPI-012, mesenchymal stem cell secretome (MSC-S), for rare and severe ocular diseases.
    • Esports Entertainment Group, Inc. (NASDAQ:GMBL) rose 9.2% to $0.4774.
    • Argo Blockchain plc (NASDAQ:ARBK) gained 9.1% to $4.7563.
    • Helbiz, Inc. (NASDAQ:HLBZ) rose 8% to $0.6901 after declining around 10% on Tuesday.
    • Bilibili Inc. (NASDAQ:BILI) gained 8% to $25.01.
    • Zai Lab Limited (NASDAQ:ZLAB) jumped 7.8% to $46.73.
    • Baidu, Inc. (NASDAQ:BIDU) gained 6.5% to $146.67. Baidu, on Tuesday, reported better-than-expected Q2 EPS results.


    Losers

    • NewAge, Inc. (NASDAQ:NBEV) shares fell 41.7% to $0.2102 after the company announced it filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code.
    • Express, Inc. (NYSE:EXPR) dipped 21.3% to $1.5099 after the company reported worse-than-expected Q2 sales results and issued guidance.
    • Aquestive Therapeutics, Inc. (NASDAQ:AQST) fell 21.3% to $1.1959. Aquestive received FDA tentative approval for Libervant in seizure clusters management.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) shares fell 19.5% to $9.75 after the company issued Q2 sales guidance below analyst estimates and guided a Q2 comparable sales decline of approximately 26%. The company also announced cost optimization plans, which include job cuts and a discontinuation of three of its nine labels. Additionally, the company filed for a stock shelf offering.
    • Check-Cap Ltd. (NASDAQ:CHEK) declined 18.3% to $0.3474 after reporting Q2 results.
    • Bright Minds Biosciences Inc. (NASDAQ:DRUG) declined 18% to $1.8521.
    • Ambarella, Inc. (NASDAQ:AMBA) dipped 17.8% to $69.43 after the company reported Q2 earnings results and issued guidance. Summit Insights Group downgraded the stock from Buy to Hold.
    • Crown ElectroKinetics Corp. (NASDAQ:CRKN) fell 16.7% to $0.3876.
    • Mobile Global Esports Inc. (NASDAQ:MGAM) fell 16.6% to $4.42 after jumping 104% on Tuesday.
    • Tyra Biosciences, Inc. (NASDAQ:TYRA) dropped 15.7% to $6.12.
    • IDW Media Holdings, Inc. (NYSE:IDW) fell 15.6% to $1.62.
    • PaxMedica, Inc. (NASDAQ:PXMD) dipped 15% to $3.20.
    • Daktronics, Inc. (NASDAQ:DAKT) dropped 14.8% to $3.50 after the company reported worse-than-expected Q1 EPS and reported a 6.3% year-over-year drop in orders.
    • A-Mark Precious Metals, Inc. (NASDAQ:AMRK) fell 14% to $30.36 after the company reported worse-than-expected Q4 sales results.
    • ECMOHO Limited (NASDAQ:MOHO) fell 12.5% to $0.15 after gaining around 17% on Tuesday.
    • TMC the metals company Inc. (NASDAQ:TMC) fell 11.5% to $0.9899 after surging 33% on Tuesday.
    • JOANN Inc. (NASDAQ:JOAN) fell 10.8% to $7.09 after B of A Securities downgraded the stock from Neutral to Underperform.
    • Getty Images Holdings, Inc. (NYSE:GETY) dropped 9.4% to $19.41.
    • First High-School Education Group Co., Ltd. (NYSE:FHS) fell 9.2% to $0.61 after dropping 4% on Tuesday.
    • Forge Global Holdings, Inc. (NYSE:FRGE) fell 8.2% to $3.83 after jumping more than 20% on Tuesday.
    • Grab Holdings Limited (NASDAQ:GRAB) declined 7.3% to $2.8360.
    • Xometry, Inc. (NASDAQ:XMTR) dipped 7.4% to $47.29.
    • PVH Corp (NYSE:PVH) shares fell 7.2% to $58.30 as the company reported a decline in Q2 earnings, announced job cuts and issued weak outlook. The company said it now sees revenue dropping this year, versus a prior forecast projection for a gain. PVH also announced the resignation of Trish Donnelly, CEO of PVH Americas & Calvin Klein Global.
    • Chewy, Inc. (NYSE:CHWY) fell 7% to $34.78 after the company reported worse-than-expected Q2 sales results.
    • HP Inc. (NYSE:HPQ) fell 6.1% to $29.20 after the company reported weaker-than-expected sales results for its third quarter and lowered its full-year earnings guidance.
    • The Gap, Inc. (NYSE:GPS) dropped 5.1% to $9.18. Cowen & Co maintained Gap with a Market Perform and lowered the price target from $12 to $10.
    Get the next $ALLK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ALLK
    $AMBA
    $AMRK
    $APGN

    CompanyDatePrice TargetRatingAnalyst
    Chewy Inc.
    $CHWY
    2/19/2026$28.00Mkt Perform → Outperform
    Raymond James
    Tyra Biosciences Inc.
    $TYRA
    2/10/2026Outperform
    William Blair
    Snap Inc.
    $SNAP
    2/10/2026$7.30Neutral → Buy
    Arete
    Snap Inc.
    $SNAP
    2/6/2026$5.50Sell → Hold
    Stifel
    Snap Inc.
    $SNAP
    2/5/2026$10.00Neutral → Buy
    BofA Securities
    HP Inc.
    $HPQ
    2/3/2026$20.00Neutral → Underperform
    BofA Securities
    Tyra Biosciences Inc.
    $TYRA
    1/28/2026$59.00Overweight
    Barclays
    HP Inc.
    $HPQ
    1/16/2026$18.00Equal Weight → Underweight
    Barclays
    More analyst ratings

    $ALLK
    $AMBA
    $AMRK
    $APGN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Chewy upgraded by Raymond James with a new price target

    Raymond James upgraded Chewy from Mkt Perform to Outperform and set a new price target of $28.00

    2/19/26 7:46:41 AM ET
    $CHWY
    Catalog/Specialty Distribution
    Consumer Discretionary

    William Blair initiated coverage on Tyra Biosciences

    William Blair initiated coverage of Tyra Biosciences with a rating of Outperform

    2/10/26 8:03:00 AM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Snap upgraded by Arete with a new price target

    Arete upgraded Snap from Neutral to Buy and set a new price target of $7.30

    2/10/26 7:58:39 AM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    $ALLK
    $AMBA
    $AMRK
    $APGN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Accounting Officer Morrow Rebecca sold $92,939 worth of shares (19,674 units at $4.72), decreasing direct ownership by 4% to 463,507 units (SEC Form 4)

    4 - Snap Inc (0001564408) (Issuer)

    2/19/26 7:00:06 PM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    Chief Financial Officer Andersen Derek sold $296,331 worth of shares (63,041 units at $4.70), decreasing direct ownership by 2% to 3,892,617 units (SEC Form 4)

    4 - Snap Inc (0001564408) (Issuer)

    2/19/26 7:00:05 PM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    Chief Business Officer Mohan Ajit sold $561,060 worth of shares (119,339 units at $4.70), decreasing direct ownership by 2% to 5,158,477 units (SEC Form 4)

    4 - Snap Inc (0001564408) (Issuer)

    2/19/26 7:00:04 PM ET
    $SNAP
    Computer Software: Programming Data Processing
    Technology

    $ALLK
    $AMBA
    $AMRK
    $APGN
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    June 7, 2024 - FDA Roundup: June 7, 2024

    For Immediate Release: June 07, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA announced that it has advised the manufacturers of the licensed and authorized COVID-19 vaccines that the COVID-19 vaccines (2024-2025 Formula) for use in the United States should be monovalent (single strain) JN.1 vaccines to more closely match cu

    6/7/24 3:46:22 PM ET
    $GERN
    $SRAX
    $SNAP
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Advertising
    Consumer Discretionary

    FDA Approval for LIBERVANT issued to AQUESTIVE THERAPEUTICS INC

    Submission status for AQUESTIVE THERAPEUTICS INC's drug LIBERVANT (ORIG-1) with active ingredient DIAZEPAM has changed to 'Approval' on 04/26/2024. Application Category: NDA, Application Number: 218623, Application Classification: Type 9 - New Indication Submitted as Distinct NDA, Consolidated with Original NDA after Approval

    4/29/24 7:48:13 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    March 22, 2024 - FDA Roundup: March 22, 2024

    For Immediate Release: March 22, 2024 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency:  Today, the FDA issued an emergency use authorization for Pemgarda (pemivibart) for the pre-exposure prophylaxis (prevention) of COVID-19 in certain adults and adolescents (12 years of age and older weighing at least 40 kilograms [about 88 pounds]).  Pemgarda is

    3/22/24 5:02:42 PM ET
    $SNAP
    $SRAX
    Computer Software: Programming Data Processing
    Technology
    Advertising
    Consumer Discretionary

    $ALLK
    $AMBA
    $AMRK
    $APGN
    SEC Filings

    View All

    Daktronics Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

    8-K - DAKTRONICS INC /SD/ (0000915779) (Filer)

    2/20/26 4:36:17 PM ET
    $DAKT
    Miscellaneous manufacturing industries
    Consumer Discretionary

    SEC Form PRE 14C filed by Getty Images Holdings Inc.

    PRE 14C - Getty Images Holdings, Inc. (0001898496) (Filer)

    2/20/26 4:17:06 PM ET
    $GETY
    Real Estate

    SEC Form 8-K filed by KALA BIO Inc.

    8-K - KALA BIO, Inc. (0001479419) (Filer)

    2/20/26 4:05:55 PM ET
    $KALA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLK
    $AMBA
    $AMRK
    $APGN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Aquestive Therapeutics to Present New Clinical Data on Anaphylm™ (dibutepinephrine) Sublingual Film at the 2026 AAAAI Annual Meeting

    Anaphylm™ (dibutepinephrine) sublingual film achieved clinically relevant epinephrine plasma concentrations without diastolic blood pressure dip WARREN, N.J., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced that multiple poster presentations highlighting results from the investigational use of its product candidate Anaphylm™ (dibutepinephrine) sublingual film for the treatment of severe allergic reactions, including anaphylaxis, will be featured at the 2026 American

    2/20/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Tyra Biosciences to Participate in Upcoming Investor Conferences

    CARLSBAD, Calif., Feb. 19, 2026 /PRNewswire/ -- Tyra Biosciences, Inc. (NASDAQ:TYRA), a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) biology, today announced participation at the following investor conferences:36th Annual Oppenheimer Life Sciences Healthcare ConferenceFormat: Virtual fireside chat and one-on-one investor meetingsPresentation Date/Time: Thursday, February 26, 2026 at 12:00pm ETLocation: Virtual46th Annual TD Cowen Healthcare ConferenceFormat: Hybrid presentation & fireside chat and one-on-one investor meetingsPresentation Date/Time: Wednesday, March 4t

    2/19/26 4:05:00 PM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Pentagon Pours $68M Into Hypersonic Tech: Here Are Five Firms Building the Hardware

    Issued on behalf of Starfighters SpaceVANCOUVER, BC, Feb. 19, 2026 /CNW/ -- USANewsGroup.com News Commentary – The Pentagon's Joint Hypersonics Transition Office has awarded $68 million across six vendors to accelerate next-generation technologies capable of traveling faster than Mach 5[1]. The U.S. Army has begun fielding Dark Eagle, the nation's first operational ground-launched hypersonic weapon, with delivery expected to complete in early 2026[2]. Companies positioned at the intersection of commercial aerospace and defense testing include Starfighters Space (NYSE-A: FJET), Rocket Lab (NASDAQ:RKLB), Intuitive Machines (NASDAQ:LUNR), Kratos Defense & Security Solutions (NASDAQ:KTOS), and J

    2/19/26 9:45:00 AM ET
    $FJET
    $JOBY
    $KTOS
    Air Freight/Delivery Services
    Consumer Discretionary
    Aerospace
    Industrials

    $ALLK
    $AMBA
    $AMRK
    $APGN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Paulson & Co. Inc. bought $15,625,000 worth of shares (2,500,000 units at $6.25) (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    11/28/25 5:38:39 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Officer Smiley Joshua L bought $289,100 worth of American Depositary Shares (10,000 units at $28.91), increasing direct ownership by 13% to 86,604 units (SEC Form 4)

    4 - Zai Lab Ltd (0001704292) (Issuer)

    9/12/25 4:32:44 PM ET
    $ZLAB
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Director Paulson John bought $312,490,062 worth of shares (34,721,118 units at $9.00) (SEC Form 4)

    4 - Bausch Health Companies Inc. (0000885590) (Issuer)

    8/14/25 9:35:28 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ALLK
    $AMBA
    $AMRK
    $APGN
    Leadership Updates

    Live Leadership Updates

    View All

    Aquestive Therapeutics Appoints Internationally Recognized Allergist Dr. Matthew Greenhawt as Chief Medical Officer

    Board-certified allergist and leading food allergy and anaphylaxis researcher joins Aquestive to support Anaphylm™ (dibutepinephrine) sublingual film NDA resubmission and pipeline WARREN, N.J., Feb. 18, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ:AQST) ("Aquestive" or the "Company"), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today announced the appointment of Matthew Greenhawt, MD, MBA, MSc, as Chief Medical Officer, strengthening its leadership team as the Company prepares to resubmit its Anaphylm™ New Drug Application (NDA) to the United Stated Food and Drug Admi

    2/18/26 7:00:00 AM ET
    $AQST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Sunbit Appoints Shachar G. Scott as Chief Marketing Officer to Accelerate its Next Phase of Growth

    Veteran global marketing leader joins from Meta as Sunbit scales products, partnerships and infrastructure to serve millions more consumers Sunbit, the personalized financial partner for everyday life, today announced the appointment of Shachar G. Scott as Chief Marketing Officer, signaling a pivotal next chapter in the company's growth. Scott brings more than 25 years of experience building and scaling global brands across technology and consumer products with leadership roles at Meta (NASDAQ:META), Apple (NASDAQ:AAPL), Bumble (NASDAQ:BMBL) and Snap (NYSE:SNAP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260212757677/en/S

    2/12/26 10:14:00 AM ET
    $AAPL
    $BMBL
    $META
    Computer Manufacturing
    Technology
    Computer Software: Programming Data Processing

    Nuwellis Appoints Carisa Schultz as Chief Financial Officer

    MINNEAPOLIS, Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE) a medical technology company focused on advancing precision cardiorenal care, today announced the appointment of Carisa Schultz as Chief Financial Officer, effective February 2, 2026. Ms. Schultz brings extensive healthcare and public company finance leadership experience, most recently serving as Vice President of Finance at NeueHealth (formerly Bright Health Group), a healthcare company previously listed on the New York Stock Exchange. In that role, she led enterprise finance, treasury, and corporate development activities. During her tenure at NeueHealth, she also held progressive leadership roles including A

    1/30/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    $ALLK
    $AMBA
    $AMRK
    $APGN
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Daktronics Inc.

    SC 13D/A - DAKTRONICS INC /SD/ (0000915779) (Subject)

    12/11/24 5:00:16 PM ET
    $DAKT
    Miscellaneous manufacturing industries
    Consumer Discretionary

    Amendment: SEC Form SC 13D/A filed by Tyra Biosciences Inc.

    SC 13D/A - Tyra Biosciences, Inc. (0001863127) (Subject)

    12/6/24 9:30:49 PM ET
    $TYRA
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13D/A filed by Rocket Lab USA Inc.

    SC 13D/A - Rocket Lab USA, Inc. (0001819994) (Subject)

    12/5/24 9:49:25 PM ET
    $RKLB
    Military/Government/Technical
    Industrials

    $ALLK
    $AMBA
    $AMRK
    $APGN
    Financials

    Live finance-specific insights

    View All

    BAUSCH HEALTH ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2025 RESULTS

    Fourth Quarter Consolidated Revenues of $2.80 billion, up 9% on a Reported basis and up 6% on an Organic (non-GAAP)1 basis over the prior year periodFull-Year Consolidated Revenues of $10.27 billion, up 7% on a Reported basis and 5% on an Organic (non-GAAP)1 basisGAAP Net Loss Attributable to Bausch Health of $112 million for the quarter and GAAP Net Income Attributable to Bausch Health of $157 million for the yearConsolidated Adjusted EBITDA Attributable to Bausch Health (non-GAAP)1 of $1.05 billion for the quarter, up 13%, and $3.54 billion for the year, up 7%BAUSCH HEALTH EXCLUDING BAUSCH + LOMB FOURTH QUARTER AND FULL-YEAR 2025 RESULTSDelivered eleventh consecutive quarter of year-over-y

    2/18/26 4:05:00 PM ET
    $BHC
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ChargePoint to Announce Fourth Quarter and Fiscal Year 2026 Financial Results on March 4, 2026

    ChargePoint Holdings, Inc. (NYSE:CHPT) ("ChargePoint" or the "Company"), a leading provider of EV charging solutions, today announced it will release financial results for the fourth quarter and full fiscal year 2026, which ended January 31, 2026, on March 4, 2026. ChargePoint will host a conference call to review the Company's financial results at 1:30 p.m. Pacific time (4:30 p.m. Eastern time) on the same day. A live webcast of the conference call will be available at https://events.q4inc.com/attendee/850090218. Participants can also access the conference call by dialing +1 (800) 715-9871 (North America toll free) or +1 (646) 307-1963 (international) and Conference ID 1744120. A replay

    2/17/26 4:15:00 PM ET
    $CHPT
    Industrial Specialties
    Consumer Discretionary

    Bilibili Inc. to Report Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results on Thursday, March 5, 2026

    SHANGHAI, Feb. 12, 2026 (GLOBE NEWSWIRE) -- Bilibili Inc. ("Bilibili" or the "Company") (NASDAQ:BILI), an iconic brand and a leading video community for young generations in China, today announced that it will report its fourth quarter and fiscal year 2025 unaudited financial results on Thursday, March 5, 2026, before the open of U.S. markets. The Company's management will host an earnings conference call at 7:00 AM U.S. Eastern Time on March 5, 2026 (8:00 PM Beijing/Hong Kong Time on March 5, 2026). Details for the conference call are as follows: Event Title:Bilibili Inc. Fourth Quarter and Fiscal Year 2025 Earnings Conference CallRegistration Link:https://register-conf.media-server.com/

    2/12/26 5:00:00 AM ET
    $BILI
    EDP Services
    Technology